Table 3.
SUA measurement | Model A | Model B | Model C | Model D | |
---|---|---|---|---|---|
Baseline (visit 1) | HR† | 1.30 | 1.25 | 1.16 | 1.07 |
95% CI | 1.21, 1.40 | 1.15, 1.36 | 1.06,1.26 | 0.97, 1.17 | |
p-value | <0.01 | <0.01 | <0.01 | 0.12 | |
| |||||
Mean value | HR | 1.24 | 1.20 | 1.14 | 1.07 |
95% CI | 1.18,1.31 | 1.13,1.27 | 1.08,1.21 | 1.01,1.14 | |
p-value | <0.01 | <0.01 | <0.01 | <0.01 | |
| |||||
Time varying | HR | 1.29 | 1.27 | 1.24 | 1.18 |
95% CI | 1.02,1.63 | 1.00,1.63 | 0.97,1.57 | 0.95,1.48 | |
p-value | 0.03 | 0.04 | 0.07 | 0.12 |
HR: hazard ratio indicates adjusted relative hazards per standard deviation (SD) of serum uric acid difference at visit 1 (SD= 1.56 mg/dl).
Model A adjusts simultaneously for age, sex, race, education and field center.
Model B adjusts simultaneously for all variables in model A as well as, body mass index, alcohol use, serum glucose, systolic and diastolic blood pressure, and LDL-cholesterol.
Model C adjusts simultaneously for all variables in model B as well as, prevalent coronary heart disease and heart failure, serum creatinine, use of diuretics and p wave duration on ECG at baseline.
Model D adjusts for Model C, and censors individuals when they develop incident myocardial infarction or heart failure.